These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 9280188

  • 1. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
    Grimsgaard S, Bonaa KH, Hansen JB, Nordøy A.
    Am J Clin Nutr; 1997 Sep; 66(3):649-59. PubMed ID: 9280188
    [Abstract] [Full Text] [Related]

  • 2. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
    Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ.
    Am J Clin Nutr; 2002 Nov; 76(5):1007-15. PubMed ID: 12399272
    [Abstract] [Full Text] [Related]

  • 3. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.
    Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, Beilin LJ.
    Am J Clin Nutr; 2000 May; 71(5):1085-94. PubMed ID: 10799369
    [Abstract] [Full Text] [Related]

  • 4. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans.
    Grimsgaard S, Bønaa KH, Hansen JB, Myhre ES.
    Am J Clin Nutr; 1998 Jul; 68(1):52-9. PubMed ID: 9665096
    [Abstract] [Full Text] [Related]

  • 5. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia.
    Hansen JB, Grimsgaard S, Nilsen H, Nordøy A, Bønaa KH.
    Lipids; 1998 Feb; 33(2):131-8. PubMed ID: 9507234
    [Abstract] [Full Text] [Related]

  • 6. Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects.
    Buckley R, Shewring B, Turner R, Yaqoob P, Minihane AM.
    Br J Nutr; 2004 Sep; 92(3):477-83. PubMed ID: 15469651
    [Abstract] [Full Text] [Related]

  • 7. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.
    Vidgren HM, Agren JJ, Schwab U, Rissanen T, Hänninen O, Uusitupa MI.
    Lipids; 1997 Jul; 32(7):697-705. PubMed ID: 9252957
    [Abstract] [Full Text] [Related]

  • 8. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans.
    Mori TA, Bao DQ, Burke V, Puddey IB, Beilin LJ.
    Hypertension; 1999 Aug; 34(2):253-60. PubMed ID: 10454450
    [Abstract] [Full Text] [Related]

  • 9. The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro.
    Krokan HE, Bjerve KS, Mørk E.
    Biochim Biophys Acta; 1993 May 20; 1168(1):59-67. PubMed ID: 8504143
    [Abstract] [Full Text] [Related]

  • 10. Docosahexaenoic and eicosapentaenoic acids in plasma phospholipids are divergently associated with high density lipoprotein in humans.
    Bønaa KH, Bjerve KS, Nordøy A.
    Arterioscler Thromb; 1992 Jun 20; 12(6):675-81. PubMed ID: 1534256
    [Abstract] [Full Text] [Related]

  • 11. Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans.
    Rambjør GS, Wålen AI, Windsor SL, Harris WS.
    Lipids; 1996 Mar 20; 31 Suppl():S45-9. PubMed ID: 8729093
    [Abstract] [Full Text] [Related]

  • 12. Chronic administration of eicosapentaenoic acid and docosahexaenoic acid as ethyl esters reduced plasma cholesterol and changed the fatty acid composition in rat blood and organs.
    Frøyland L, Vaagenes H, Asiedu DK, Garras A, Lie O, Berge RK.
    Lipids; 1996 Feb 20; 31(2):169-78. PubMed ID: 8835405
    [Abstract] [Full Text] [Related]

  • 13. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K, Kralovec J, Bailey-Hall E, Smeberg V, Stark JG, Salem N.
    Lipids Health Dis; 2015 Sep 02; 14():99. PubMed ID: 26328782
    [Abstract] [Full Text] [Related]

  • 14. Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial.
    Asztalos IB, Gleason JA, Sever S, Gedik R, Asztalos BF, Horvath KV, Dansinger ML, Lamon-Fava S, Schaefer EJ.
    Metabolism; 2016 Nov 02; 65(11):1636-1645. PubMed ID: 27733252
    [Abstract] [Full Text] [Related]

  • 15. Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects.
    Conquer JA, Holub BJ.
    J Nutr; 1996 Dec 02; 126(12):3032-9. PubMed ID: 9001371
    [Abstract] [Full Text] [Related]

  • 16. Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans.
    Egert S, Kannenberg F, Somoza V, Erbersdobler HF, Wahrburg U.
    J Nutr; 2009 May 02; 139(5):861-8. PubMed ID: 19261730
    [Abstract] [Full Text] [Related]

  • 17. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
    Goyens PL, Mensink RP.
    Eur J Clin Nutr; 2006 Aug 02; 60(8):978-84. PubMed ID: 16482073
    [Abstract] [Full Text] [Related]

  • 18. EPA+DHA, but not ALA, Improved Lipids and Inflammation Status in Hypercholesterolemic Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Zhou Q, Zhang Z, Wang P, Zhang B, Chen C, Zhang C, Su Y.
    Mol Nutr Food Res; 2019 May 02; 63(10):e1801157. PubMed ID: 30900815
    [Abstract] [Full Text] [Related]

  • 19. The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humans.
    Nelson GJ, Schmidt PC, Bartolini GL, Kelley DS, Kyle D.
    Lipids; 1997 Nov 02; 32(11):1137-46. PubMed ID: 9397398
    [Abstract] [Full Text] [Related]

  • 20. Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2,4-dienoyl-CoA reductase gene expression in rats.
    Willumsen N, Vaagenes H, Lie O, Rustan AC, Berge RK.
    Lipids; 1996 Jun 02; 31(6):579-92. PubMed ID: 8784738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.